+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

All Ages
All Genders
ID07819526

Clinical Study of Stroke Recurrence and Characteristics in Patients With Acute Ischemic Stroke and Active Cancer A Multicenter Prospective Observational Study

Led by Osaka University · Updated on 2026-09-21

500

Participants Needed

1

Research Sites

248 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a multicenter prospective observational study across 24 hospitals in Japan to understand recurrent ischemic stroke in people with active cancer who experience acute ischemic stroke. The study aims to find out how often ischemic stroke recurs within three months, which clinical factors may be linked to recurrence, and what other clinical outcomes occur during follow-up. Participants receive medical care determined by their own doctors and are not assigned to specific treatments by this study. Information about their cancer, stroke details, test results, treatments, and subsequent clinical outcomes, including recurrent ischemic stroke, will be collected during the study period. Participants will be followed up for three months after enrollment to observe for recurrent ischemic stroke and other health events. The primary outcome measured is the percentage of participants who experience a recurrent ischemic stroke within this timeframe. The study will gather clinical data and outcomes without altering standard medical care.

CONDITIONS

Brief Title

Acute Ischemic Stroke in Patients With Active Cancer

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here